The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
- 28 June 2023
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 258, 115606
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Innate Immune Interleukin-1 Receptor–Associated Kinase 4 Exacerbates Viral Myocarditis by Reducing CCR5 + CD11b + Monocyte Migration and Impairing Interferon ProductionCirculation, 2013
- Inflammation's Yin-YangScience, 2013
- Cancer-related inflammationNature, 2008
- IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine bindingBioorganic & Medicinal Chemistry Letters, 2008
- Design, Synthesis, and In Vitro Activity of Peptidomimetic Inhibitors of Myeloid Differentiation Factor 88Journal of Medicinal Chemistry, 2008
- IRAK-4 – a shared NF-κB activator in innate and acquired immunityTrends in Immunology, 2006
- Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a GatekeeperStructure, 2006
- Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4Bioorganic & Medicinal Chemistry Letters, 2006
- Inflammation and cancerNature, 2002
- Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4Nature, 2002